6:33 PM
 | 
Dec 17, 2012
 |  BC Extra  |  Company News

Phenex, Janssen in discovery deal for nuclear receptor

Phenex Pharmaceuticals AG (Ludwigshafen, Germany) and Janssen Biotech Inc. partnered to discover compounds against RAR-related orphan receptor C thymus-specific isoform ( RORgamma2; RORgammaT) to treat...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >